Fabio Sciano

Via Archirafi 32
Palermo, 90123, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Polyphenolic Imidazopyridines as Multifunctional Modulators of Oxidative Stress, Metal Dyshomeostasis, and β1-42 Amyloid Aggregation in an In Vitro Model of Alzheimer's Disease.

Polyphenolic Imidazopyridines as Multifunctional Modulators of Oxidative Stress, Metal Dyshomeostasis, and β1-42 Amyloid Aggregation in an In Vitro Model of Alzheimer's Disease.

Journal: Antioxidants (Basel, Switzerland)

Published: May 22, 2026

Imidazo[2,1-b][1,3,4]thiadiazol-2-yl]-1H-pyrrolo[2,3-b]pyridines as Inhibitors of Staphylococcus aureus Biofilm Formation.

Imidazo[2,1-b][1,3,4]thiadiazol-2-yl]-1H-pyrrolo[2,3-b]pyridines as Inhibitors of Staphylococcus aureus Biofilm Formation.

Journal: Antibiotics (Basel, Switzerland)

Published: April 21, 2026

Toxic aldehydes in cooking vegetable oils: Generation, toxicity and disposal methods.

Toxic aldehydes in cooking vegetable oils: Generation, toxicity and disposal methods.

Journal: Food chemistry: X

Published: December 04, 2024

Corrigendum to "Synthesis and biological evaluation of a new class of azole urea compounds as Akt inhibitors with promising anticancer activity in pancreatic cancer models" [Bioorg. Chem. 153 (2024) 107959].

Corrigendum to "Synthesis and biological evaluation of a new class of azole urea compounds as Akt inhibitors with promising anticancer activity in pancreatic cancer models" [Bioorg. Chem. 153 (2024) 107959].

Journal: Bioorganic chemistry

Published: November 30, 2024

The challenging inhibition of Aldose Reductase for the treatment of diabetic complications: a 2019-2023 update of the patent literature.

The challenging inhibition of Aldose Reductase for the treatment of diabetic complications: a 2019-2023 update of the patent literature.

Journal: Expert opinion on therapeutic patents

Published: October 04, 2024

Synthesis and biological evaluation of a new class of azole urea compounds as Akt inhibitors with promising anticancer activity in pancreatic cancer models.

Synthesis and biological evaluation of a new class of azole urea compounds as Akt inhibitors with promising anticancer activity in pancreatic cancer models.

Journal: Bioorganic chemistry

Published: September 27, 2024

Exploring the therapeutic potential of a novel series of imidazothiadiazoles targeting focal adhesion kinase (FAK) for pancreatic cancer treatment: synthesis, mechanistic insights and promising antitumor and safety profile.

Exploring the therapeutic potential of a novel series of imidazothiadiazoles targeting focal adhesion kinase (FAK) for pancreatic cancer treatment: synthesis, mechanistic insights and promising antitumor and safety profile.

Journal: Journal of drug targeting

Published: July 27, 2024

Treatment resistance in pancreatic and biliary tract cancer: molecular and clinical pharmacology perspectives.

Treatment resistance in pancreatic and biliary tract cancer: molecular and clinical pharmacology perspectives.

Journal: Expert review of clinical pharmacology

Published: February 27, 2024

Novel [1,3,4]Thiadiazole[3,2-a]pyrimidin-5-ones as Promising Biofilm Dispersal Agents against Relevant Gram-Positive and Gram-Negative Pathogens.

Novel [1,3,4]Thiadiazole[3,2-a]pyrimidin-5-ones as Promising Biofilm Dispersal Agents against Relevant Gram-Positive and Gram-Negative Pathogens.

Journal: Marine drugs

Published: February 17, 2024

Exploring the therapeutic potential of focal adhesion kinase inhibition in overcoming chemoresistance in pancreatic ductal adenocarcinoma.

Exploring the therapeutic potential of focal adhesion kinase inhibition in overcoming chemoresistance in pancreatic ductal adenocarcinoma.

Journal: Future medicinal chemistry

Published: January 25, 2024

Showing 1-10 of 10

Last Updated: 09/26/2026